Doxylamine Succinate | m-entrepreneurship.com

Product Name :
Doxylamine Succinate

Search keywords :
Doxylamine

drugId :
null

Target Vo:
Histamine H1 receptor

Target Vo Short Name :
HRH1

Moa_Name:
Histamine H1 receptor antagonists

First Approval Country :
United States

First Approval Date Filter:
1948

Origin Company_Name :
Sanofi

Active Company_Name :
Jiangxi Xinganjiang Pharmaceutical Co Ltd

Active Indication_Name:

In Active Indication_Name:
Hypersensitivity

Termination Status :

China Termination Status :

Highest Status:
IND

China Highest Status:
IND

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Ocaratuzumab site
Visilizumab medchemexpress
PI3 Kinase p85 beta Antibody (YA688): PI3 Kinase p85 beta Antibody (YA688) is a non-conjugated and Mouse origined monoclonal antibody about 82 kDa, targeting to PI3 Kinase p85 beta (8D9). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts